Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and
commercialization of medical technologies that improve patient health outcomes. We are committed to keeping
a compliant, accurate, and well articulated Investor Relations page. Here you should find a wide range of
information relating to Corporate Governance Policies, Regulatory Filings, Stock Information, along with recently
updated Corporate Materials including our Company Presentation and other related documents. If you have any
questions, please contact Harrison Ross, VP of Finance, at IR@marizyme.com.
Read More